Pump Supplies denied as not FDA-approved for this use by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for pump supplies are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Pump Supplies as "Not FDA-Approved" — and How to Appeal

Blue Cross Blue Shield occasionally issues a "not FDA-approved" denial for insulin pump supplies (infusion sets, reservoirs, CGM sensors, and related consumables) when the specific device, accessory, or supply item does not appear on the insurer's internal approved-device list or when the claim lacks sufficient documentation tying the item to an FDA-cleared system. This is almost always a documentation or coding problem rather than a genuine regulatory deficiency, because the major pump supply categories are FDA-cleared as medical devices.

## Why This Denial Is Appealable

FDA clearance (510(k)) or approval for a device class does not mean every code a supplier bills is automatically matched on an insurer's internal list. If your supplies are components of or accessories to an FDA-cleared insulin pump or continuous glucose monitor, that regulatory status is documentable and the denial can be overturned. BCBS is required under its own coverage policies — and under applicable state and federal law — to cover medically necessary, FDA-cleared diabetes management devices when clinical criteria are met.

## Federal Appeal Framework

• Internal appeal: File within the timeframe printed on your Explanation of Benefits (EOB), typically 180 days from the denial date.
• ACA §2719 / external review: If the internal appeal is denied, you have the right to an independent external review under the ACA. The standard external-review window is approximately four months from the final internal denial; expedited external review (72-hour decision) is available when your health is at urgent risk.
• ERISA §503: If your plan is employer-sponsored, ERISA's full-and-fair review standard applies, requiring the insurer to disclose every reason for denial and every standard used.

## Concrete Appeal Steps

1. Request the complete denial letter and internal coverage/medical policy BCBS applied. 2. Obtain from the device manufacturer the FDA 510(k) clearance number and the cleared indications for each supply item billed. 3. Ask your prescriber to write a medical-necessity letter (see below). 4. Submit a written internal appeal with all supporting documents within the deadline on your EOB. 5. If denied internally, file for independent external review immediately.

## Documentation to Gather

• Diagnosis confirmation: Chart notes establishing your diabetes diagnosis and the clinical rationale for pump therapy versus alternative delivery methods.
• Device records: Serial number of your pump or CGM, manufacturer name, and FDA clearance documentation for the device and the specific supply items.
• Prior-treatment history: Dates and outcomes of any previous insulin delivery methods, including reasons pump therapy was selected.
• Prescriber medical-necessity letter: Your endocrinologist or prescribing clinician should state why pump therapy is medically necessary for you, why these specific supply items are required components of that therapy, and that the supplies are compatible with your FDA-cleared device.
• Manufacturer compatibility documentation: A letter or published compatibility guide from the pump manufacturer confirming the supplies are indicated for use with your specific cleared device.

## Criteria-Mapping Structure

Pull the exact language from (a) the FDA clearance document for your pump system and (b) BCBS's published medical policy for insulin pumps and supplies. Create a two-column table: left column lists each requirement; right column cites the exact chart note, device document, or letter that satisfies it. This direct mapping is the single most effective tool for overturning a technical denial.